AbbVie Inc. Earnings Per Share (Diluted)
AbbVie Inc. (ABBV) reported Earnings Per Share (Diluted) of $2.03 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-03
- AbbVie Inc. earnings per share, diluted for the quarter ending 2026-06-30 was $2.03, a 290.38% increase year-over-year.
- AbbVie Inc. earnings per share, diluted for the quarter ending 2026-03-31 was $0.39, a 45.83% decline year-over-year.
- AbbVie Inc. earnings per share, diluted for the quarter ending 2025-12-31 was $1.02.
- AbbVie Inc. earnings per share, diluted for the quarter ending 2025-09-30 was $0.10, a 88.64% decline year-over-year.
- AbbVie Inc. earnings per share, diluted for fiscal 2025 was $2.36, a 1.26% decline from fiscal 2024.
- AbbVie Inc. earnings per share, diluted for fiscal 2024 was $2.39, a 12.13% decline from fiscal 2023.
- AbbVie Inc. earnings per share, diluted for fiscal 2023 was $2.72, a 58.97% decline from fiscal 2022.
- AbbVie Inc. earnings per share, diluted for fiscal 2022 was $6.63, a 2.79% increase from fiscal 2021.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.03 10-Q · filed 2026-08-03 | $2.42 10-Q · filed 2026-08-03 | $3.43 derived: net income ÷ weighted average shares · filed 2026-08-03 | $3.53 derived: net income ÷ weighted average shares · filed 2026-08-03 |
| 2026-03-31 | $0.39 10-Q · filed 2026-05-08 | $1.40 derived: net income ÷ weighted average shares · filed 2026-05-08 | $1.50 derived: net income ÷ weighted average shares · filed 2026-05-08 | $2.03 derived: net income ÷ weighted average shares · filed 2026-08-03 |
| 2025-12-31 | $1.02 10-K · filed 2026-02-20 | $1.12 derived: net income ÷ weighted average shares · filed 2026-02-20 | $1.64 derived: net income ÷ weighted average shares · filed 2026-08-03 | $2.36 10-K · filed 2026-02-20 |
| 2025-09-30 | $0.10 10-Q · filed 2025-11-04 | $0.62 derived: net income ÷ weighted average shares · filed 2026-08-03 | $1.34 10-Q · filed 2025-11-04 | $1.32 derived: net income ÷ weighted average shares · filed 2026-08-03 |
| 2025-06-30 | $0.52 10-Q · filed 2026-08-03 | $1.24 10-Q · filed 2026-08-03 | $1.23 derived: net income ÷ weighted average shares · filed 2026-08-03 | $2.10 derived: net income ÷ weighted average shares · filed 2026-08-03 |
| 2025-03-31 | $0.72 10-Q · filed 2026-05-08 | $0.70 derived: net income ÷ weighted average shares · filed 2026-05-08 | $1.58 derived: net income ÷ weighted average shares · filed 2026-05-08 | $2.34 derived: net income ÷ weighted average shares · filed 2026-05-08 |
| 2024-12-31 | -$0.02 10-K · filed 2025-02-14 | $0.86 derived: net income ÷ weighted average shares · filed 2026-02-20 | $1.62 derived: net income ÷ weighted average shares · filed 2026-02-20 | $2.39 10-K · filed 2026-02-20 |
| 2024-09-30 | $0.88 10-Q · filed 2025-11-04 | $1.64 derived: net income ÷ weighted average shares · filed 2025-11-04 | $2.41 10-Q · filed 2025-11-04 | $2.87 derived: net income ÷ weighted average shares · filed 2026-02-20 |
| 2024-06-30 | $0.77 10-Q · filed 2025-08-04 | $1.53 10-Q · filed 2025-08-04 | $1.99 derived: net income ÷ weighted average shares · filed 2026-02-20 | $2.99 derived: net income ÷ weighted average shares · filed 2026-02-20 |
| 2024-03-31 | $0.77 10-Q · filed 2025-05-09 | $1.22 derived: net income ÷ weighted average shares · filed 2026-02-20 | $2.22 derived: net income ÷ weighted average shares · filed 2026-02-20 | $3.36 derived: net income ÷ weighted average shares · filed 2026-02-20 |
| 2023-12-31 | $0.46 10-K · filed 2024-02-20 | $1.45 derived: net income ÷ weighted average shares · filed 2026-02-20 | $2.59 derived: net income ÷ weighted average shares · filed 2026-02-20 | $2.72 10-K · filed 2026-02-20 |
| 2023-09-30 | $1.00 10-Q · filed 2024-11-04 | $2.13 derived: net income ÷ weighted average shares · filed 2024-11-04 | $2.26 10-Q · filed 2024-11-04 | $3.65 derived: net income ÷ weighted average shares · filed 2025-02-14 |
| 2023-06-30 | $1.14 10-Q · filed 2024-08-07 | $1.26 10-Q · filed 2024-08-07 | $2.65 derived: net income ÷ weighted average shares · filed 2025-02-14 | $4.86 derived: net income ÷ weighted average shares · filed 2025-02-14 |
| 2023-03-31 | $0.13 10-Q · filed 2024-05-03 | $1.51 derived: net income ÷ weighted average shares · filed 2025-02-14 | $3.72 derived: net income ÷ weighted average shares · filed 2025-02-14 | $4.24 derived: net income ÷ weighted average shares · filed 2025-02-14 |
| 2022-12-31 | $1.38 10-K · filed 2023-02-17 | $3.59 derived: net income ÷ weighted average shares · filed 2025-02-14 | $4.11 derived: net income ÷ weighted average shares · filed 2025-02-14 | $6.63 10-K · filed 2025-02-14 |
| 2022-09-30 | $2.21 10-Q · filed 2023-11-06 | $2.73 derived: net income ÷ weighted average shares · filed 2023-11-06 | $5.24 10-Q · filed 2023-11-06 | $7.50 derived: net income ÷ weighted average shares · filed 2024-02-20 |
| 2022-06-30 | $0.51 10-Q · filed 2023-08-07 | $3.03 10-Q · filed 2023-08-07 | $5.29 derived: net income ÷ weighted average shares · filed 2024-02-20 | $7.07 derived: net income ÷ weighted average shares · filed 2024-02-20 |
| 2022-03-31 | $2.51 10-Q · filed 2023-05-05 | $4.77 derived: net income ÷ weighted average shares · filed 2024-02-20 | $6.55 derived: net income ÷ weighted average shares · filed 2024-02-20 | $6.97 derived: net income ÷ weighted average shares · filed 2024-02-20 |
| 2021-12-31 | $2.26 10-K · filed 2022-02-18 | $4.04 derived: net income ÷ weighted average shares · filed 2024-02-20 | $4.46 derived: net income ÷ weighted average shares · filed 2024-02-20 | $6.45 10-K · filed 2024-02-20 |
| 2021-09-30 | $1.78 10-Q · filed 2022-11-04 | $2.20 derived: net income ÷ weighted average shares · filed 2022-11-04 | $4.19 10-Q · filed 2022-11-04 | $4.20 derived: net income ÷ weighted average shares · filed 2023-02-17 |
| 2021-06-30 | $0.42 10-Q · filed 2022-08-04 | $2.41 10-Q · filed 2022-08-04 | $2.42 derived: net income ÷ weighted average shares · filed 2023-02-17 | $3.71 derived: net income ÷ weighted average shares · filed 2023-02-17 |
| 2021-03-31 | $1.99 10-Q · filed 2022-05-06 | $2.00 derived: net income ÷ weighted average shares · filed 2023-02-17 | $3.29 derived: net income ÷ weighted average shares · filed 2023-02-17 | $2.91 derived: net income ÷ weighted average shares · filed 2023-02-17 |
| 2020-12-31 | $0.01 10-K · filed 2021-02-19 | $1.30 derived: net income ÷ weighted average shares · filed 2023-02-17 | $0.90 derived: net income ÷ weighted average shares · filed 2023-02-17 | $2.72 10-K · filed 2023-02-17 |
| 2020-09-30 | $1.29 10-Q · filed 2021-11-02 | $0.90 derived: net income ÷ weighted average shares · filed 2021-11-02 | $2.77 10-Q · filed 2021-11-02 | $4.58 derived: net income ÷ weighted average shares · filed 2022-02-18 |
| 2020-06-30 | -$0.46 10-Q · filed 2021-08-02 | $1.43 10-Q · filed 2021-08-02 | $3.27 derived: net income ÷ weighted average shares · filed 2022-02-18 | $4.53 derived: net income ÷ weighted average shares · filed 2022-02-18 |
| 2020-03-31 | $2.02 10-Q · filed 2021-05-07 | $3.89 derived: net income ÷ weighted average shares · filed 2022-02-18 | $5.16 derived: net income ÷ weighted average shares · filed 2022-02-18 | $5.65 derived: net income ÷ weighted average shares · filed 2022-02-18 |
| 2019-12-31 | $1.88 10-K · filed 2020-02-21 | $3.14 derived: net income ÷ weighted average shares · filed 2022-02-18 | $3.63 derived: net income ÷ weighted average shares · filed 2022-02-18 | $5.28 10-K · filed 2022-02-18 |
| 2019-09-30 | $1.26 10-Q · filed 2020-11-04 | $1.76 derived: net income ÷ weighted average shares · filed 2020-11-04 | $3.41 10-Q · filed 2020-11-04 | $2.17 derived: net income ÷ weighted average shares · filed 2021-02-19 |
| 2019-06-30 | $0.49 10-Q · filed 2020-08-04 | $2.14 10-Q · filed 2020-08-04 | $0.91 derived: net income ÷ weighted average shares · filed 2021-02-19 | $2.73 derived: net income ÷ weighted average shares · filed 2021-02-19 |
| 2019-03-31 | $1.65 10-Q · filed 2020-05-08 | $0.42 derived: net income ÷ weighted average shares · filed 2021-02-19 | $2.24 derived: net income ÷ weighted average shares · filed 2021-02-19 | $3.51 derived: net income ÷ weighted average shares · filed 2021-02-19 |
| 2018-12-31 | -$1.23 10-K · filed 2020-02-21 | $0.61 derived: net income ÷ weighted average shares · filed 2021-02-19 | $1.89 derived: net income ÷ weighted average shares · filed 2021-02-19 | $3.66 10-K · filed 2021-02-19 |
| 2018-09-30 | $1.81 10-K · filed 2020-02-21 | $3.05 derived: net income ÷ weighted average shares · filed 2019-11-06 | $4.79 10-Q · filed 2019-11-06 | $4.79 derived: net income ÷ weighted average shares · filed 2020-02-21 |
| 2018-06-30 | $1.26 10-K · filed 2020-02-21 | $2.99 10-Q · filed 2019-08-05 | $3.01 derived: net income ÷ weighted average shares · filed 2020-02-21 | $4.03 derived: net income ÷ weighted average shares · filed 2020-02-21 |
| 2018-03-31 | $1.74 10-K · filed 2020-02-21 | $1.76 derived: net income ÷ weighted average shares · filed 2020-02-21 | $2.78 derived: net income ÷ weighted average shares · filed 2020-02-21 | $3.97 derived: net income ÷ weighted average shares · filed 2020-02-21 |
| 2017-12-31 | $0.03 10-K · filed 2019-02-27 | $1.04 derived: net income ÷ weighted average shares · filed 2020-02-21 | $2.23 derived: net income ÷ weighted average shares · filed 2020-02-21 | $3.30 10-K · filed 2020-02-21 |
| 2017-09-30 | $1.01 10-K · filed 2019-02-27 | $2.20 derived: net income ÷ weighted average shares · filed 2018-11-07 | $3.27 10-Q · filed 2018-11-07 | $4.11 derived: net income ÷ weighted average shares · filed 2019-02-27 |
| 2017-06-30 | $1.19 10-K · filed 2019-02-27 | $2.25 10-Q · filed 2018-08-07 | $3.10 derived: net income ÷ weighted average shares · filed 2019-02-27 | $4.07 derived: net income ÷ weighted average shares · filed 2019-02-27 |
| 2017-03-31 | $1.06 10-K · filed 2019-02-27 | $1.91 derived: net income ÷ weighted average shares · filed 2019-02-27 | $2.88 derived: net income ÷ weighted average shares · filed 2019-02-27 | $3.86 derived: net income ÷ weighted average shares · filed 2019-02-27 |
| 2016-12-31 | $0.85 10-K · filed 2018-02-16 | $1.82 derived: net income ÷ weighted average shares · filed 2019-02-27 | $2.80 derived: net income ÷ weighted average shares · filed 2019-02-27 | $3.63 10-K · filed 2019-02-27 |
| 2016-09-30 | $0.97 10-K · filed 2018-02-16 | $1.95 derived: net income ÷ weighted average shares · filed 2017-11-07 | $2.78 10-Q · filed 2017-11-07 | $3.70 derived: net income ÷ weighted average shares · filed 2018-02-16 |
| 2016-06-30 | $0.98 10-K · filed 2018-02-16 | $1.81 10-Q · filed 2017-08-07 | $2.73 derived: net income ÷ weighted average shares · filed 2018-02-16 | $3.47 derived: net income ÷ weighted average shares · filed 2018-02-16 |
| 2016-03-31 | $0.83 10-K · filed 2018-02-16 | $1.75 derived: net income ÷ weighted average shares · filed 2018-02-16 | $2.49 derived: net income ÷ weighted average shares · filed 2018-02-16 | |
| 2015-12-31 | $0.92 10-K · filed 2017-02-17 | $1.66 derived: net income ÷ weighted average shares · filed 2018-02-16 | $3.13 10-K · filed 2018-02-16 | |
| 2015-09-30 | $0.74 10-K · filed 2017-02-17 | $2.21 10-Q · filed 2016-11-07 | ||
| 2015-06-30 | $0.83 10-K · filed 2017-02-17 | $1.47 10-Q · filed 2016-08-05 | ||
| 2015-03-31 | $0.63 10-K · filed 2017-02-17 | |||
| 2014-12-31 | -$0.51 10-K · filed 2016-02-19 | $1.10 10-K · filed 2017-02-17 | ||
| 2014-09-30 | $0.31 10-K · filed 2016-02-19 | $1.60 10-Q · filed 2015-11-06 | ||
| 2014-06-30 | $0.68 10-K · filed 2016-02-19 | $1.29 10-Q · filed 2015-08-07 | ||
| 2014-03-31 | $0.61 10-K · filed 2016-02-19 | |||
| 2013-12-31 | $0.70 10-K · filed 2015-02-20 | $2.56 10-K · filed 2016-02-19 | ||
| 2013-09-30 | $0.60 10-K · filed 2015-02-20 | $1.86 10-Q · filed 2014-11-07 | ||
| 2013-06-30 | $0.66 10-K · filed 2015-02-20 | $1.27 10-Q · filed 2014-08-07 | ||
| 2013-03-31 | $0.60 10-K · filed 2015-02-20 | |||
| 2012-12-31 | $0.98 10-K · filed 2014-02-21 | $3.35 10-K · filed 2015-02-20 | ||
| 2012-09-30 | $1.01 10-K · filed 2014-02-21 | $2.37 10-Q · filed 2013-11-12 | ||
| 2012-06-30 | $0.80 10-K · filed 2014-02-21 | $1.36 10-Q · filed 2013-08-09 | ||
| 2012-03-31 | $0.56 10-K · filed 2014-02-21 | |||
| 2011-12-31 | $2.18 10-K · filed 2014-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |